Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
Mahasen Al-Najar(University of Jordan), Abdalla Awidi(University of Jordan), Amenah Al Abdullah(University of Jordan), Dana Alhattab(King Abdullah University of Science and Technology), Hiba B. Khalil(Al-Neelain University), Mohamad Samih Yasin(University of Jordan), Eman T. Al‐Antary(University of Jordan), Mohammad Hamdan(University of Jordan), Osama Samara(University of Jordan), Hanan Jafar(University of Jordan), Esraa Al-jabbari(University of Jordan), Dima Hmaid(University of Jordan), Jihad M. Al-Ajlouni(University of Jordan), Reem Rahmeh(University of Jordan)
Cited by 141
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123
Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial
|Urologia Internationalis|2018|109
Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
|OpenNano|2023|103
Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon‐α in 1<sup>st</sup>trimester: Report of 3 cases and review of the literature
|American Journal of Hematology|2002|82